Register Cart 0

Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Back Subscribe

Perspective

Impaired Quality Control of Mitochondria Underlying the Pathogenesis of Alzheimer's Disease

Author(s): Md. Sahab Uddin*

, Umme Tabassum Arobi Katha and Ghulam Md. Ashraf*

Volume 22, Issue 14, 2021

Published on: 09 March, 2021

Page: [1578 - 1584] Pages: 7

DOI: 10.2174/1389450122666210309105326

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

25

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

World Malaria Day

Related Articles

MicroRNAs Involved in Oxidative Stress Processes Regulating Physiological and Pathological Responses
MicroRNA

Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy
Current Cancer Drug Targets

An Integrated Drug Development Approach Applying Topological Descriptors
Current Computer-Aided Drug Design

Histological and Direct Evidence for the Role of Complement in the Neuroinflammation of AD
Current Alzheimer Research

Erythropoietin Signaling and Neuroprotection
Current Signal Transduction Therapy

Developments in the Application of 1,2,3-Triazoles in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery

Lysosomal Modulatory Drugs for a Broad Strategy Against Protein Accumulation Disorders
Current Alzheimer Research

Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy

Recent Advances in Validating MDM2 as a Cancer Target
Anti-Cancer Agents in Medicinal Chemistry

Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease
CNS & Neurological Disorders - Drug Targets

Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target
Current Pharmaceutical Design

Biological Importance, Therapeutic Benefit and Analytical Aspects of Bioactive Flavonoid Pectolinarin in the Nature
Drug Metabolism Letters

Negative Regulation of NEDD8 Conjugation Pathway by Novel Molecules and Agents for Anticancer Therapy
Current Pharmaceutical Design

MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: A Field as Much Unexplored as Potentially Promising
Current Pharmaceutical Design

Podophyllotoxin: Current Perspectives
Current Bioactive Compounds

The Other Side of Opioid Receptor Signalling: Regulation by Protein-Protein Interaction
Current Drug Targets

A General Method for the Synthesis of 11H-Indeno[1,2-B]Quinoxalin- 11-Ones and 6H-Indeno[1,2-B]Pyrido[3,2-E]Pyrazin-6-One Derivatives Using Mandelic Acid as an Efficient Organo-catalyst at Room Temperature
Current Organocatalysis

Integrins in Drug Targeting-RGD Templates in Toxins
Current Pharmaceutical Design

Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy
Current Cancer Drug Targets

Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel
Current Cancer Drug Targets

© 2024 Bentham Science Publishers | Privacy Policy